An audit of osteoporotic patients in an Australian general practice

Similar documents
Guideline for the investigation and management of osteoporosis. for hospitals and General Practice

nogg Guideline for the diagnosis and management of osteoporosis in postmenopausal women and men from the age of 50 years in the UK

Osteoporosis/Fracture Prevention

They are updated regularly as new NICE guidance is published. To view the latest version of this NICE Pathway see:

Page 1

Osteoporosis. Open Access. John A. Kanis. Diseases, University of Sheffield, UK

Module 5 - Speaking of Bones Osteoporosis For Health Professionals: Fracture Risk Assessment. William D. Leslie, MD MSc FRCPC

Using the FRAX Tool. Osteoporosis Definition

Skeletal Manifestations

OSTEOPOROSIS IN INDONESIA

Summary. Background. Diagnosis

Management of postmenopausal osteoporosis

Osteoporosis challenges

Osteoporosis: fragility fracture risk. Costing report. Implementing NICE guidance

LOVE YOUR BONES Protect your future

Submission to the National Institute for Clinical Excellence on

1

Osteoporosis The Silent Disease

Case Finding and Risk Assessment for Osteoporosis

Analyses of cost-effective BMD scanning and treatment strategies for generic alendronate, and the costeffectiveness

Bone Mass Measurement BONE MASS MEASUREMENT HS-042. Policy Number: HS-042. Original Effective Date: 8/25/2008

SCHEDULE 2 THE SERVICES. A. Service Specifications

Osteoporosis. Overview

Tamer Mettyas 1* and Clare Carpenter 2

Objectives: What is Osteoporosis 10/8/2015. Bone Health/ Osteoporosis: BASICS OF SCREENING, INTERPRETING, AND TREATING

IMPROVING BONE HEALTH AND FRACTURE PREVENTION

Interpreting DEXA Scan and. the New Fracture Risk. Assessment. Algorithm

International Journal of Health Sciences and Research ISSN:

Discovering prior fractures in your postmenopausal patient may be the LINK to reducing her fragility fracture* risk in the future.

Study of secondary causes of male osteoporosis

AACE/ACE Osteoporosis Treatment Decision Tool

Horizon Scanning Technology Briefing. Zoledronic Acid (Aclasta) once yearly treatment for postmenopausal. National Horizon Scanning Centre

COPD-Related Musculoskeletal Disease. Jessica Bon Field, MD, MS 2017 Update in Internal Medicine October 20, 2017

Understanding NICE guidance. NICE technology appraisal guidance advises on when and how drugs and other treatments should be used in the NHS.

DEVELOPMENT OF A RISK SCORING SYSTEM TO PREDICT A RISK OF OSTEOPOROTIC VERTEBRAL FRACTURES IN POSTMENOPAUSAL WOMEN

New Osteoporosis Guidelines

O. Bruyère M. Fossi B. Zegels L. Leonori M. Hiligsmann A. Neuprez J.-Y. Reginster

Bone density scanning and osteoporosis

Bone Density Measurement in Women

CASE 1 WHY IS IT IMPORTANT TO TREAT? FACTS CONCERNS

Overview. Bone Biology Osteoporosis Osteomalacia Paget s Disease Cases. People Centred Positive Compassion Excellence

Fragile Bones and how to recognise them. Rod Hughes Consultant physician and rheumatologist St Peter s hospital Chertsey

Pathway from Fracture or Risk Factor to Treatment

IEHP UM Subcommittee Approved Authorization Guidelines DEXA Scan

A JOINT INITIATIVE FOR FRACTURE PREVENTION. Know Your Bones Community Risk Report October 2018

Osteoporosis: assessing the risk of fragility fracture

Costing statement: Denosumab for the prevention of osteoporotic fractures in postmenopausal women

Strong bones after 50 Fracture liaison services explained A guide for patients, carers and families

Audit on follow-up of patients with primary Osteoporosis

Clinician s Guide to Prevention and Treatment of Osteoporosis

Osteoporosis in Men Wendy Rosenthal PharmD. This program has been brought to you by PharmCon

Chapter 39: Exercise prescription in those with osteoporosis

Guidelines for the Pharmaceutical Management of Osteoporosis in Adult WA Public Hospitals

8/6/2018. Glucocorticoid induced osteoporosis: overlooked and undertreated? Disclosure. Objectives. Overview

Dumfries and Galloway. Treatment Protocol for Osteoporosis

Bone Densitometry Pathway

Strong bones after 50 Fracture liaison services explained A guide for patients, carers and families

Dr Tuan V NGUYEN. Mapping Translational Research into Individualised Prognosis of Fracture Risk

FRAX, NICE and NOGG. Eugene McCloskey Professor of Adult Bone Diseases University of Sheffield

Forteo (teriparatide) Prior Authorization Program Summary

AMERICAN COLLEGE OF RHEUMATOLOGY POSITION STATEMENT. Committee on Rheumatologic Care

NATIONAL INSTITUTE FOR HEALTH AND CARE EXCELLENCE Health and social care directorate Quality standards and indicators Briefing paper

DEXA SCAN POLICY CRITERIA BASED ACCESS

Autonomic neuropathy

Osteoporosis: Are your bones at risk of fracturing? Rachel Wallwork, MD Internal medicine resident Massachusetts General Hospital

NICE SCOOP OF THE DAY FRAX with NOGG. Eugene McCloskey Professor of Adult Bone Diseases University of Sheffield

Clinical Specialist Statement Template

Osteoporosis - New Guidelines. Michelle Glass B.Sc. (Pharm) June 15, 2011

Nutritional Aspects of Osteoporosis Care and Treatment Cynthia Smith, FNP-BC, RN, MSN, CCD Pars Osteoporosis Clinic, Belpre, Ohio

ASJ. How Many High Risk Korean Patients with Osteopenia Could Overlook Treatment Eligibility? Asian Spine Journal. Introduction

To understand bone growth and development across the lifespan. To develop a better understanding of osteoporosis.

Osteoporosis. Treatment of a Silently Developing Disease

Osteoporosis. Prevention and detection in general practice. Bones. Prevention. Prevention with lifestyle changes. Background. Objective.

All about. Osteoporosis

nice bulletin NICE provided the content for this booklet which is independent of any company or product advertised

HIV and your Bones Osteopenia and Osteoporosis

BAD TO THE BONE. Peter Jones, Rheumatologist QE Health, Rotorua. GP CME Conference Rotorua, June 2008

Learning Objectives. Controversies in Osteoporosis Prevention and Management. Etiology. Presenter Disclosure Information. Epidemiology.

Quality and Outcomes Framework Programme NICE cost impact statement July Indicator area: Osteoporosis - fragility fracture

Use of DXA / Bone Density in the Care of Your Patients. Brenda Lee Holbert, M.D. Associate Professor Senior Staff Radiologist

Aromatase Inhibitors & Osteoporosis

Original Article. Ramesh Keerthi Gadam, MD 1 ; Karen Schlauch, PhD 2 ; Kenneth E. Izuora, MD, MBA 1 ABSTRACT

Dumfries and Galloway. Treatment Protocol for Osteoporosis

A FRAX Experience in Korea: Fracture Risk Probabilities with a Country-specific Versus a Surrogate Model

Osteoporosis Clinical Guideline. Rheumatology January 2017

Osteoporosis. When we talk about osteoporosis, we have to be familiar with the constituents of bone and what it is formed of.

Osteoporosis: A Tale of 3 Task Forces!

Make your. first break. your last.

Osteodensitometry in primary and secondary osteoporosis

TREATMENT OF OSTEOPOROSIS

Fracture Risk Prediction Using Phalangeal Bone Mineral Density or FRAX Ò?dA Danish Cohort Study on Men and Women

Efficacy of risedronate in men with primary and secondary osteoporosis: results of a 1-year study

Advanced medicine conference. Monday 20 Tuesday 21 June 2016

Horizon Scanning Centre March Denosumab for glucocorticoidinduced SUMMARY NIHR HSC ID: 6329

Prevent the next fracture. GP Guide

NIH Public Access Author Manuscript Endocr Pract. Author manuscript; available in PMC 2014 May 11.

Focusing on the Patient: Diagnosis and Management of Osteoporosis

Beyond the T-score: New Thinking in Osteoporosis 2

Pharmacy Management Drug Policy

What Is FRAX & How Can I Use It?

Transcription:

professional Darren Parker An audit of osteoporotic patients in an Australian general practice Background Osteoporosis is a major contributor to morbidity and mortality in Australia, and is predicted to accelerate as the population grows and increases in age. The aim of this study was to audit 10 general practitioners for their identification of patients with risk factors for osteoporosis, and appropriate screening, treatment and follow up care. Method Patient medical records over a 12 year period from 10 GPs at a rural medical centre were retrospectively audited using the PENCAT software. The management of osteoporosis was compared with guidelines from The Royal Australian College of General Practitioners. Results The study included 402 patients, both men and women, aged 60 95 years, with at least one risk factor in addition to age. Only 35% of all patients had been scanned for osteoporosis, and the percentage varied with age, gender, and number and type of risk factors. Overall, 66% of patients with osteopenia, and 26% with osteoporosis, were receiving no medical treatment. Additionally, 48% of those with previous low bone mineral density scans had not had recommended follow up scans. Recommendations General practitioners are the healthcare hubs of our communities, including for prevention of diseases such as osteoporosis. The low level of concordance with the guidelines suggests that in this general practice community, passive screening for osteoporosis has been less than effective. Active surveillance, such as the PENCAT tool used in this study, would offer an alternative approach. Further studies could then evaluate whether incorporating this into the usual practice audit process leads to improved patient outcomes. Keywords osteoporosis; clinical audit; general practice Osteoporosis is a common condition where the bones lose their mineral content and density. This eventually leads to frail, brittle bones that have an increased risk of fracturing under minimal stress. Osteoporosis is defined by the World Health Organization as a bone mineral density (BMD) of >2.5 standard deviations below the peak bone mass of an average 20 year old, as measured by a duelenergy X-ray absorptiometry (DXA) scan. Osteoporotic fractures are very common, with a fracture occurring every 3 seconds and a vertebral fracture every 22 seconds worldwide. 1 Osteoporosis currently affects 10% of the Australian population, with $1.9 billion being spent in 2007 on direct costs associated with this disease. 2 Unfortunately, it appears that many individuals are not being appropriately diagnosed or treated for osteoporosis in Australian general practice, as the majority of individuals considered to be high risk (having at least one previous osteoporotic fracture) are neither identified nor treated. 3 A study of over 8800 postmenopausal Australian women showed that almost one-third had an osteoporotic fracture, yet more than 80% of these women had neither been investigated nor treated to reduce their risk of a further fracture. 4 These women carry a considerable risk of long term morbidity and mortality for osteoporotic fractures. Morbidity and mortality Peripheral, vertebral and hip fractures associated with osteoporosis can happen as a result of minimal trauma to weakened bones. These fractures often have a wide range of effects on patients, both physically and psychologically, including short term pain and morbidity, and long term loss of height, bone deformities, chronic pain, disability and death. Hip fractures in particular are the most serious consequence of osteoporosis, with 24% estimated to die within 12 months, 5 and an increased risk of death for at least another 4 years. 6 Guidelines There are a number of guidelines regarding risk calculation for osteoporosis, however, these often differ substantially on their recommendations. Reprinted from Australian Family Physician Vol. 42, No. 6, JuNE 2013 423

professional An audit of osteoporotic patients in an Australian general practice Fortunately, they all generally agree that there are a number of important risk factors for osteoporosis, such as age, previous vertebral fracture, and low trauma fracture. Any fracture following minimal trauma Possible vertebral fracture Back pain Height loss Kyphosis Spine X-ray to identify/confirm wedge or crush fracture This study applied guidelines from The Royal Australian College of General Practitioners (RACGP), 7 as these are widely used by general practitioners in Australia. Presence of major risk factors Age over 60 years Family history of osteoporotic fractures Hypogonadism Prolonged (>3 months) glucocorticoid use Inflammatory conditions Malabsorption Hyperparathyroidism Hyperthyroidism Low body weight Smoking Recurrent falls High alcohol intake (>2 4 standard drinks per day for men, less for women) BMD test DXA of spine or proximal femur (desirable but not essential for patients with fracture) Figure 1. The RAGCP recommendations for bone mineral density scanning 7 Reproduced with permission Clinical guideline for the prevention and treatment of osteoporosis in postmenopausal women and older men. The RACGP, 2010 Table 1. Major risk factors for osteoporosis 7 Age (over 60 years) One or more vertebral or low trauma fracture Prolonged glucocorticoid therapy (>7.5 mg prednislone or equivalent >3 months) Excess alcohol intake (2 4 standard drinks per day for men, 1 2 standard drinks per day for women, over 5 days per week) Male or female hypogonadism Primary hyperparathyroidism or thyroxine excess Chronic liver or renal disease Rheumatoid arthritis Malabsorption Low BMI (<20) Family history of hip fracture Immobilisation Current smoker Glucocorticoid secretion More than one fall in the past year Source Clinical guideline for the prevention and treatment of osteoporosis in postmenopausal women and older men. The RACGP, 2010 The RACGP guideline recommends BMD scanning for any person with a minimal trauma fracture or vertebral fracture confirmed on spinal X-ray (Figure 1), or the presence of major risk factors, including age >60 years, low body weight, and being a cigarette smoker (Table 1). The aim of this study was to audit 10 GPs for their identification of patients with risk factors for osteoporosis, plus appropriate screening, treatment and follow up care. Method Selection and description of participants The medical records of 10 GPs from a rural medical centre in New South Wales for the period 1 January 2000 through to 20 March 2012 were audited. Both men and women aged >60 years with at least one additional osteoporotic risk factor were evaluated for their screening and treatment status, ie. the population requiring DXA screening and at clear risk of osteoporotic complications. In total, there were 7347 active (three or more visits in 2 years) and long term (over 2 years) patients in the practice database, with 1589 aged >60 years. Information collected included whether a DXA scan had been performed, the result (normal, osteopenia or osteoporosis), and the nature of treatment types (Figure 2). Each patient s notes were examined and those with extenuating circumstances such as patient refused DXA scan or patient refused treatment were excluded. Technical information Information was extracted from the practice database using the Best Practice software and the clinical audit tool (PENCAT) developed by Pen Computer Systems. 8 Simple frequency analysis was used to highlight the differences in the patients gender, age, and risk factors in relation to the management (screening, treatment and follow up care) of osteoporosis. Results There were 402 subjects: 185 men (46%) and 217 women (54%), aged 60 95 years (71.5 +/ 8.6 [mean +/ standard deviation]). The most common risk factors were glucocorticoid 424 Reprinted from Australian Family Physician Vol. 42, No. 6, JuNE 2013

An audit of osteoporotic patients in an Australian general practice professional use (195), high alcohol intake (143), previous fracture (62), and smoking (42). Low frequencies were recorded for excessive thyroxine dosage (18), rheumatoid arthritis (10), low body mass index (BMI) (8), malabsorption (3), and primary hyperparathyroidism (2). The prevalence of individual risk factors is outlined in Figure 3. Risk factors vs scanning In addition to age, patients had a total number of risk factors ranging between one and six. Men had on average 1.7 risk factors, and women 2.8. The largest group was individuals with two risk factors (172) representing 43% of the total group (Table 2). This group also had the most even distribution of men (53%) to women (47%). From the 172 individuals in this group only 50 (29%) had been screened for osteoporosis; however, as the risk factors increased, the number of DXA screening rate also increased. For example, patients with three risk factors had a screening rate of 49%, four risk factors at 51.7%, and at five risk factors the screening rate was 67%. Interestingly, all the patients with one risk factor (77) were male and only 12 (16%) of these patients had previously been scanned for BMD. Additionally, eight (67%) of these individuals that were scanned showed low BMD. Women accounted for 137 (90%) of the 153 individuals with multiple (3 6) risk factors and 77 (56%) of these individuals were screened for osteoporosis. According to the guidelines, 7 any individual with low trauma fracture or vertebral fracture should receive a DXA scan. Only 25% of the individuals in this cohort with a fracture alone received a DXA scan. This figure rose as risk factors were added to individuals with fractures. For example, 44% were scanned with a fracture plus one risk factor, 60% for fracture plus two risk factors, and 79% for fracture plus three risk factors (Table 3). Regarding the risk factors alone, the screening rates were relatively high for: previous fracture (56%), low BMI (63%), primary hyperparathyroidism (100%), and rheumatoid arthritis (50%). Low screening rates were shown for smokers (21%) and those with a high alcohol intake (15%). Finally, regarding age groups, those aged 60 69 years had a scan rate between 20% and 27%. The scan rate then peaked at between 49% and 50% for those aged 70 79 years, and then dropped to between 25% and 30% for those aged 80 95 years. Percent 100 90 80 70 60 50 40 30 20 10 0 15% 85% 27% 65% Table 2. Risk factors vs DXA scan 8% Management Of the 402 patients in this data set, 139 (35%) had DXA scans, of which 36 (26%) showed a normal scan, 64 (46%) showed osteopenia, and 39 (28%) showed osteoporosis. Of those with a normal scan, five (14%) patients were Risk Total Percentage Male Female Had DXA Percentage One risk factor 77 19.0% 77 0 12 16% Two risk factors 172 43.0% 92 80 50 29% Three risk factors 120 30.0% 14 106 59 49% Four risk factors 29 7.0% 2 27 15 52% Five risk factors 3 0.75% 0 3 2 67% Six risk factors 1 0.25% 0 1 1 100% Total 402 100% 185 217 139 (Avg) 35% 59% 15% 26% Normal Osteopenia Osteoporosis Figure 2. Osteoporosis status vs treatment type 62 195 Previous fracture Prolonged glucocorticoid therapy Male hypogonadism Primary hyperparathyroidism Chronic renal disease Rheumatoid arthritis 1 2 6 Figure 3. Prevalence of individual risk factors 10 18 Thyroxine excess Malabsorption Low BMI (<20) Smoking Alcohol 3 8 Bone density conservation Bone mineral supplement Lifestyle/no treatment 42 143 Reprinted from Australian Family Physician Vol. 42, No. 6, JuNE 2013 425

professional An audit of osteoporotic patients in an Australian general practice Table 3. Fracture + risk factors vs DXA scan Fracture + risks Total Percentage Male Female Had DXA Percentage Fracture alone 4 6.45% 4 0 1 25% One risk factor 18 29.03% 8 10 8 44% Two risk factors 25 40.32% 4 21 15 60% Three risk factors 14 22.58% 0 14 11 79% Four risk factors 1 1.61% 0 1 0 0% Total 62 100% 16 46 45 (Avg) 73% Table 4. Treatment of osteopenia and osteoporosis 7 Osteopenia Consider preventive anti-osteoporotic therapy Calcium and vitamin D supplements when dietary intake is inadequate, and, depending on the degree of osteopenia/ osteoporosis: Bisphosphonates Hormone therapy Strontium ranelate (women only) prescribed calcium supplements. Within the osteopenia group, five (8%) individuals were receiving bone density conservation therapy, 18 (28%) were receiving bone mineral supplements, and 42 (66%) were either being treated with lifestyle changes or not receiving any treatment. Finally, of the osteoporosis patients, 23 (59%) were receiving bone density conservation therapy, only six (15%) were receiving bone mineral supplements, and 10 (26%) were receiving no treatment at all (Figure 2). Follow up care Of the 402 patients, 132 had DXA scan(s) in the period from 2000 to 2012, of which 36 patients (26%) were reported normal and 101 patients (74%) showed low BMD. The RAGCP guidelines recommend that all patients with risk factors for osteoporosis be scanned by DXA, not only for diagnosis, but also for baseline and follow up care. Osteoporosis Initiate anti-osteoporotic therapy Calcium and vitamin D supplements when dietary intake is inadequate Bisphosphonates Hormone therapy Parathyroid hormone (teriparatide) Selective oestrogen receptor modulators (SERMs) Strontium ranelate (women only) Source Clinical guideline for the prevention and treatment of osteoporosis in postmenopausal women and older men. The RACGP, 2010 In this study, the last DXA scan was recorded in order to assess the ongoing management of patients with a recorded diagnosis of osteopenia or osteoporosis. It is recommended that patients be scanned at least every 2 years after a diagnosis, however, the data show that although 53 (52%) of the patients had their last DXA scan between 2010 and 2012, a further 48 (48%) have not had any follow up scanning beyond 2 years. Discussion This study found that only 1 in 3 patients were correctly identified as having one or more major risk factors and subsequently considered for a DXA scan. There were a number of interesting patterns that emerged from this study regarding who was screened and who was missed. First, the total number of risk factors for each individual, correlated to their chance of receiving a DXA scan. For example, patients with one risk factor had a 16% chance of receiving a scan while those with four risk factors had a 52% chance. If one of these risk factors included a low trauma or vertebral fracture, this figure again rose sharply, and those with four risk factors including a fracture, were scanned at 79%. This highlights that general practitioners understand the importance of fractures above other risk factors; however, this still leaves a large percentage of patients with multiple risk factors for osteoporosis (including some with fractures) undiagnosed and without treatment. Women were also more likely to be screened at 46% compared with a low of 21% for men. This is not surprising, as although the RAGCP guidelines treat men and women equally, a number of other guidelines, such as The World Health Organization Fracture Risk Assessment Tool (FRAX ), 9 regard women more at risk than men. Age was an important factor impacting the decision to order DXA scans. Low screening rates were recorded for those aged less than 70 years or more than 80 years, peaking in-between. This study also measured appropriate management. Those with known osteopenia should be treated with lifestyle changes, bone mineral supplements, and possibly bone density conservation therapy (Table 4). However, 66% were not receiving any form of treatment (not including lifestyle changes) and only 28% were receiving bone mineral supplements, such as calcium and vitamin D. Additionally, of the patients with known osteoporosis, only 59% were receiving bone density conservation therapy (the mainstay of treatment), and 15% were receiving bone mineral supplements only. This has left 26% of known osteoporosis patients receiving no treatment at all. These figures broadly suggest that either the primary care management of osteoporosis is not adequate or some other factor is interfering with these results. Limitations The accuracy of the recorded clinical data underpinning this study is unknown. For example, lifestyle changes may have been 426 Reprinted from Australian Family Physician Vol. 42, No. 6, JuNE 2013

An audit of osteoporotic patients in an Australian general practice professional recommended and not recorded, or a DXA scan considered and then not acted upon especially if there were issues accessing Medicare funding for the scan. Recommendations 8. Pen Computer Systems. Clinical Audit Tool. V3.5. Available at www.clinicalaudit.com.au [Accessed 20 May 2013]. 9. Kanis JA, Johnell O, Oden A, Johansson H, McCloskey E. FRAX and the assessment of fracture probability in men and women from the UK, Osteoporos Int 2008;19:385 97. General practitioners are the healthcare hubs of our communities, including for prevention of diseases such as osteoporosis. The low level of concordance with the guidelines suggests that in this general practice community, passive screening for osteoporosis has been less than effective. Active surveillance, such as the PENCAT tool used in this study, would offer an alternative approach. Further studies could then evaluate whether incorporating this into the usual practice audit process leads to improved patient outcomes. Author Darren Parker MBBS, is junior medical officer, Wollongong Hospital, Wollongong, New South Wales. parkerdarren@gmail.com. Competing interests: None. Provenance and peer review: Not commissioned; externally peer reviewed. References 1. Johnell O, Kanis JA. An estimate of the worldwide prevalence and disability associated with osteoporotic fractures. Osteoporos Int 2006;17:1726. 2. Osteoporosis Australia. The burden of brittle bones epidemiology, costs and burden of osteoporosis in Australia, 2007. Available at www.osteoporosis.org.au/images/stories/documents/research/burdenbrittle_oa_2007.pdf [Accessed 20 April 2013]. 3. Nguyen TV, Center JR, Eisman JA. Osteoporosis: underrated, underdiagnosed and undertreated. Med J Aust 2004;180:18 22. 4. Eisman J, Claphman S, Kehoe L. Osteoporosis prevalence and levels of treatment in primary care. The Australian Bone Study. J Bone Miner Res 2004;19:1969 75. 5. Osteoporosis Australia. Osteoporosis GP snapshot, 2011. Available at www.osteoporosis.org. au/images/stories/documents/internal/gp%20 snapshot.pdf [Accessed 20 April 2013]. 6. Johnell O, Kanis JA, Oden A, et al. Mortality after osteoporotic fractures. Osteoporos Int 2004;15:38 42. 7. The Royal Australian College of General Practitioners. Clinical guideline for the prevention and treatment of osteoporosis in postmenopausal women and older men. Available at www.racgp.org.au/your-practice/ guidelines/musculoskeletal/osteoporosis/ [Accessed 13 May 2013]. Reprinted from Australian Family Physician Vol. 42, No. 6, JuNE 2013 427